The prevalence of Addison's disease (chronic adrenal failure) has not been widely investigated and is usually given as 39 in a million. We conducted a prevalence study using a postal survey of general practitioners in Coventry. Three quarters (1391188) replied, representing 79/85 (93%) of the practices. Thirty cases of Addision's disease were found from a total patient list of 323 852, of which a third were tuberculous in origin and twothirds non-tuberculous (12I30 autoimmune, 8/30 unclassified). We conclude that Addison's disease is 2.4 times more common than previously reported. The tuberculous group was older, 65 vs 52 years (p<0.05), and had had the disease for longer than the non-tuberculous group, 20 vs 12 years (p<0.05). There was no significant difference in the age at diagnosis.
Since Thomas Addison first described the condition of chronic adrenal failure, its prevalence has rarely been defined. In 1968, a hospital-based survey found a prevalence of 39 in a million.' This seemed likely to be an underestimate and we performed a prevalence study in a West Midlands industrial city in the UK.
Methods
In 1992 general practitioners (GPs) on the Coventry Family Health Services Authority (FHSA) list were asked by post if they had any patients with Addison's disease (chronic adrenal failure) on their practice lists. Non-responders were telephoned. We sought at least one reply per practice. Cases were also sought in a hospital endocrine clinic. The population size was taken from the FHSA patient list for July 1992. Medical records were examined for evidence of primary adrenal failure. These patients were divided into a tuberculous and an autoimmune group. Those cases that could not be placed in either group were added to the autoimmune group to form a non-tuberculous group. The statistics were performed using a Student's t-test.
Results
The survey was sent to 188 GPs in 85 practices, looking after 323 852 patients. Replies were received from 139 (74%) of the GPs in 79 (93%) of the practices. Of the six practices that did not reply, four were singlehanded and two double-handed. A total of 30 patients with Addison's disease were identified, of whom 26 were found in general practice, two in the hospital endocrine clinic and two from other sources. All patients were registered with Coventry GPs. Ten patients were not being followed up in a hospital clinic. In 25 patients there was a description of their clinical state at presentation and 24 had recorded biochemical evidence of hypocortisolaemia. Of the six that did not have a record of their cortisol state at presentation, all were being treated for Addison's disease. One had bilateral adrenal calcification on X-ray, one had had a tuberculous kidney removed, one presented in an Addisonian crisis and with pulmonary tuberculosis, two were diagnosed elsewhere and for one no other information was available.
Of the 30 patients, 10 (five men, five women) were classified as tuberculous (table  1) , 12 (two men, 10 women) were classified as autoimmune (table 2) and eight (five men, three women) had no evidence of tuberculous, autoimmune or other infiltrative disease, making 20 (seven men, 13 women) non-tuberculous cases. The prevalence was calculated as 93 in a million, 33% of whom were tuberculous. The majority (26/30) had one or more of the following features of primary adrenal failure: increased pigmentation at presentation, adrenal calcification on X-ray, no response to a (table 2) . In the non-tuberculous group the sex ratio (M/F) was 1.9/1 and 7/20 (35%) had clinical or subclinical thyroid disease. These figures compare with a sex ratio of 1.7/1 and 31% with thyroid disease in Kasperlik-Zaluska et aP and it is likely that our cases have been correctly classified. The finding that two quite different disease processes produce adrenal failure at a similar age and that the tuberculous patients are older and have had Addison's disease for longer is interesting. We cannot tell from this work whether this is due to a change in the relative incidence of tuberculous and autoimmune adrenal disease or whether the latter has a higher mortality risk, perhaps due to an associated disease such as diabetes mellitus.
